You’re eight months sober and have been taking sertraline since early treatment. Your sober living house tests every Monday, and this week the line next to BZO on your cup doesn’t show up. You haven’t touched a benzodiazepine. Now you need to explain that to a house manager who has heard plenty of explanations before.
It can happen.
A handful of common psychiatric medications are known to trigger the first stage of a drug screen. Drug testing was designed with this problem in mind, though, and a flagged screen is where the checking should begin.
Why a Screen Can Flag a Medication You Take
Most drug tests start with an immunoassay, a fast and inexpensive screen that uses antibodies built to latch onto a specific drug or drug class. The instant cups and dip cards used in most sober living homes and outpatient offices work this way. Same goes for the first screen at a lab.
Antibodies recognize molecules by shape. If a medication, or something your body breaks it down into, looks similar enough to the target, the antibody can bind to it anyway.
This is called cross-reactivity, and it’s the reason a screening result is treated as preliminary. A 2014 review in the Journal of Analytical Toxicology gathered reports of false positives across nearly every major drug class. Its authors concluded that an immunoassay positive should be considered presumptive until a second, independent method confirms it.
On paperwork, a flagged sample may be described as “non-negative” or “presumptive positive.” If the wording on a lab report leaves you guessing, this plain-English glossary of drug testing terms explains each one and links to the official source behind it.
Psychiatric Medications With Documented Cross-Reactions
Three widely prescribed medications come up repeatedly in the research:
| Medication | Can screen positive for | What the evidence shows |
| Sertraline (Zoloft) | Benzodiazepines | Its FDA prescribing information lists false-positive benzodiazepine screens as a known effect |
| Bupropion (Wellbutrin) | Amphetamines | In a review of more than 10,000 urine screens at one hospital’s emergency department, 41% of false-positive amphetamine results came from patients taking bupropion |
| Quetiapine (Seroquel) | Tricyclic antidepressants, methadone | Documented in published case reports, including a case series of psychiatric inpatients |
Cross-reactivity varies from one brand of test kit to another, so plenty of people take these medications for years without a flagged result. Which drugs the test looks for matters too, and this is where recovery testing differs from a typical job screen.
The standard federal workplace panel doesn’t include benzodiazepines, methadone, or tricyclic antidepressants. Expanded panels often do, and those are the panels used by treatment programs and sober living homes, along with many drug courts and probation offices. That makes the sertraline and quetiapine cross-reactions much more likely to come up in recovery than at a pre-employment screen. For someone who isn’t prescribed methadone, a false methadone result from quetiapine can look like use of a drug they’ve never taken.
Other Psychiatric Medications That Can Flag a Standard Panel
Amphetamines and PCP
Amphetamines and PCP appear on nearly every panel, from a basic five-panel workplace test to the 12-panel cups common in sober living. Bupropion isn’t the only psychiatric medication with a known cross-reaction for one of them.
Venlafaxine
Venlafaxine (Effexor), an SNRI prescribed for depression and anxiety, has been reported to cause false-positive PCP screens. In a 2002 report in Clinical Chemistry, researchers traced the problem to both venlafaxine and its main metabolite, O-desmethylvenlafaxine, and reproduced the cross-reaction in the lab. That metabolite is also prescribed on its own as desvenlafaxine (Pristiq).
Trazodone
Trazodone is often prescribed for sleep in early recovery, partly because it isn’t a controlled substance, so some people don’t think of it as an antidepressant at all. The body breaks it down into a compound called meta-chlorophenylpiperazine (m-CPP). A 2011 study in the Journal of Analytical Toxicology found that m-CPP can produce false-positive amphetamine results on some immunoassays. If you take trazodone, put it on the medication list you give your program, even if you only use it now and then.
Lamotrigine
Lamotrigine (Lamictal), a mood stabilizer used in bipolar disorder, carries a warning in its prescribing information that it can interfere with some rapid urine drug screens. PCP is the result it most often affects.
These reactions depend on the specific test kit, just like the ones in the table, and many people take these drugs without ever seeing a flagged result.
Psychiatric medications are only part of the picture. Common cold and allergy medicines can also trigger a screen, and alcohol-based mouthwash can show up on the EtG tests some programs use to check for alcohol. This overview of what can cause a false positive drug test covers those and other everyday causes.
What Happens After a Flagged Screen
In a lab-based program, a non-negative screen goes on to confirmation testing. Labs use gas chromatography-mass spectrometry (GC/MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), which identify the exact molecule in the sample. Sertraline’s own prescribing information names GC/MS as the way to tell it apart from a benzodiazepine.
In recovery settings, confirmation isn’t always an automatic process. Some sober living homes and outpatient programs send any non-negative cup to a lab, while others act on the instant result.
It’s fair to ask whether a positive was confirmed before any decision is made about your housing or your care. Asking about the confirmation policy at intake, before you need it, is even better.
Prescribed benzodiazepines are a related but separate case. If you take one for anxiety, a positive for that class is accurate, because the medication is there. Treatment programs and sober living homes set their own rules about prescribed controlled medications, and some don’t allow certain ones at all. Ask how your program verifies prescriptions and handles a positive for a medication you take, and get the answer before you move in or start.
If You’re Also Tested for Work
Many people in recovery are also tested by an employer. In Department of Transportation (DOT) testing, and in many employer programs built on the same model, a confirmed result goes to a Medical Review Officer (MRO). This physician contacts you before reporting anything and gives you the chance to explain a prescription. If it checks out, the result is generally reported as negative.
That privacy has limits. Under DOT rules, the MRO must share medical information with your employer if it suggests you’re medically unqualified for your job or that continuing safety-sensitive work poses a significant risk. When the concern is a medication, your prescriber gets up to five business days to resolve it first. Programs outside DOT set their own rules, so check your employer’s written testing policy.
What You Can Do Before and After a Test
- Keep a current list of everything you take, including over-the-counter medications and supplements, along with your prescriber’s contact details. Give a copy to your house manager or counselor at intake.
- Ask how your program handles a non-negative result, including whether it sends cups to a lab.
- If a screen flags, ask whether it was confirmed and request the result in writing.
- Don’t stop or skip a psychiatric medication to get through a test. Stopping some medications abruptly can bring on discontinuation symptoms or a return of the symptoms they treat. It may not help anyway, since sertraline’s prescribing information notes that false-positive results can continue for several days after the last dose.
- If someone in your recovery circle suggests coming off your medication, take the question to your prescriber. AA’s own pamphlet on medications makes the same point: no member should “play doctor,” and medical advice belongs with a qualified physician.
Keeping a Flagged Screen in Perspective
A flagged test while you’re taking a prescribed antidepressant or antipsychotic is a question that still needs an answer. Screening is built to cast a wide net, and confirmation testing exists because the people who designed these programs expected some lookalike molecules to get caught in it.
If you know which of your medications can cross-react and who to ask about confirmation, the next flagged result will be easier to sort out. Psychiatric treatment can be part of a recovery plan, and a screening result is no reason to stop it.
Sources
Saitman A, et al. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38(7):387-396. https://doi.org/10.1093/jat/bku075
Zoloft (sertraline) prescribing information, §2.6 and §7.3. Viatris; 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108%2C20990s062lbl.pdf
Casey ER, et al. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay. J Med Toxicol. 2011;7(2):105-108. https://pmc.ncbi.nlm.nih.gov/articles/PMC3724447/
Sloan KL, et al. Quetiapine and false-positive urine drug testing for tricyclic antidepressants. Am J Psychiatry. 2000;157(1):148-149. https://doi.org/10.1176/ajp.157.1.148-a
Fischer M, et al. False-positive methadone drug screens during quetiapine treatment. J Clin Psychiatry. 2010;71(12):1696. https://www.psychiatrist.com/jcp/false-positive-methadone-drug-screens-during-quetiapine/
Sena SF, et al. False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine. Clin Chem. 2002;48(4):676-677. https://pubmed.ncbi.nlm.nih.gov/11901076/
Farley TM, et al. False-positive PCP on urine drug screen attributed to desvenlafaxine (Pristiq) use. BMJ Case Rep. 2017;bcr-2017-222106. https://pmc.ncbi.nlm.nih.gov/articles/PMC5720316/
Baron JM, et al. The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results. J Anal Toxicol. 2011;35(6):364-368. https://doi.org/10.1093/anatox/35.6.364
Lamictal (lamotrigine) prescribing information, §5.14. GlaxoSmithKline; 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020241s068s069,020764s061s062,022251s032s033lbl.pdf
U.S. Department of Transportation. 49 CFR Part 40, §§40.82, 40.135 and 40.327. https://www.ecfr.gov/current/title-49/subtitle-A/part-40
Alcoholics Anonymous World Services. The A.A. Member—Medications and Other Drugs (P-11). https://www.aa.org/aa-member-medications-and-other-drugs